BioVie Inc.   Report issue

For profit Phase 3
Founded: Beverley MA United States (2013)

Organization Overview

First Clinical Trial
2017
NCT03107091
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

BioVie Inc.

Active Ingredients

Drugs in Phase 3 Trials (2)

ne3107 (4 trials)

terlipressin (Terlivaz) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Ascites (Phase 3)

Fibrosis (Phase 3)

Liver Cirrhosis (Phase 3)

Recurrence (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 6
  • # of Trial APIs: 2